Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edward Torres Insider Profile
4 Followers
Edward Torres, Director at GlobeImmune, holds 267.89K shares in GlobeImmune (Ticker: GBIM), holds 0.00 shares in Receptos (Ticker: RCPT). Most recently, Edward Torres Sold ― shares of GlobeImmune on Mar 21, 2016 for an estimated value of 43.47K.
Profitable Transactions
1 out of 7 Profitable Transactions
Average Return
-282.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Edward Torres holds in companies
Most Profitable Insider Trade
The most profitable trade made by Edward Torres
Edward Torres's Trading History
GlobeImmune
Mar 21, 2016
Director
Informative Sell
43.47K
$13.39K
Receptos
Aug 27, 2015
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Edward Torres's performance on stock
You May Also Like
Edward Torres insider profile FAQ
What is the percentage of profitable transactions made by Edward Torres?
The percentage of profitable transactions made by Edward Torres is 14%.
What is the average return per transaction made by Edward Torres?
The average return per transaction made by Edward Torres is -282.60%.
What stocks does Edward Torres hold?
Edward Torres holds: GBIM, RCPT stocks.
What was Edward Torres’s latest transaction?
Edward Torres latest transaction was an Informative Sell of $43.47K.
What was Edward Torres's most profitable transaction?
Edward Torres’s most profitable transaction was an Informative Sell of GBIM stock on March 21, 2016. The return on the trade was 75.10%.
What is Edward Torres's role in GlobeImmune?
Edward Torres's role in GlobeImmune is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.